Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS30078886HIVENSG00000154229.12protein_codingPRKCANoNo5578P17252
Q7Z727
TVIS30077335HIVENSG00000154229.12protein_codingPRKCANoNo5578P17252
Q7Z727
TVIS30019550HIVENSG00000154229.12protein_codingPRKCANoNo5578P17252
Q7Z727
TVIS30044808HIVENSG00000154229.12protein_codingPRKCANoNo5578P17252
Q7Z727
TVIS30044809HIVENSG00000154229.12protein_codingPRKCANoNo5578P17252
Q7Z727
TVIS30044810HIVENSG00000154229.12protein_codingPRKCANoNo5578P17252
Q7Z727
TVIS20003334HPVENSG00000154229.12protein_codingPRKCANoNo5578P17252
Q7Z727
TVIS20044172HPVENSG00000154229.12protein_codingPRKCANoNo5578P17252
Q7Z727
TVIS20066218HPVENSG00000154229.12protein_codingPRKCANoNo5578P17252
Q7Z727
TVIS20017200HPVENSG00000154229.12protein_codingPRKCANoNo5578P17252
Q7Z727
TCGA Plot Options
Drug Information
GenePRKCA
DrugBank IDDB06641
Drug NamePerifosine
Target IDBE0001132
UniProt IDP17252
Regulation Type
PubMed IDs16528479
CitationsKnowling M, Blackstein M, Tozer R, Bramwell V, Dancey J, Dore N, Matthews S, Eisenhauer E: A phase II study of perifosine (D-21226) in patients with previously untreated metastatic or locally advanced soft tissue sarcoma: A National Cancer Institute of Canada Clinical Trials Group trial. Invest New Drugs. 2006 Sep;24(5):435-9.
GroupsInvestigational
Direct ClassificationDialkyl phosphates
SMILESCCCCCCCCCCCCCCCCCCOP([O-])(=O)OC1CC[N+](C)(C)CC1
Pathways
PharmGKB
ChEMBLCHEMBL372764